(600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing
Filed with SSE · Stock code 600833 · · 2 pages · Chinese
Summary by 6ix AI
The briefing took place via an online interactive format, allowing for investor engagement regarding the company's financial results and operational performance. Investors raised questions about recent performance and dividend plans, to which the company provided responses during the meeting. The company reported a slight decline in revenue but a significant increase in net profit compared to the previous year.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai No. 1 Pharmacy Co. Ltd. on 6ix
Story so far
Earlier from Shanghai No. 1 Pharmacy
- (600833)"Shanghai No.1 Pharmacy Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Change in Accounting Policies
- Announcement on Abnormal Fluctuations in Stock Trading
- Semi-annual Performance Forecast for 2026
- Announcement on Implementation of Dividend Distribution for 2025
Follow Shanghai No. 1 Pharmacy into a list and get an email when it puts out news.
Follow Shanghai No. 1 Pharmacy